Carmen Martínez

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

Catalina Abad, Carmen Martínez, Marı́a G. Juarranz et al. · Gastroenterology · 2003 · 254 citations · Full text

Inflammation, Autoimmune Disease, Medicine +8

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.

Mario Delgado, Carmen Martínez, David Pozo et al. · PubMed · 1999 · 202 citations

Inflammation, Cytokine, Autoimmune Disease +15

Vasoactive Intestinal Peptide (VIP) and Pituitary Adenylate Cyclase-Activation Polypeptide (PACAP) Protect Mice from Lethal Endotoxemia Through the Inhibition of TNF-α and IL-6

Mario Delgado, Carmen Martínez, David Pozo et al. · The Journal of Immunology · 1999 · 181 citations · Full text

Acute Lung Injury, Gastrointestinal Pharmacology, Immune Regulation +19

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endotoxin-induced IL-6 production by murine peritoneal macrophages

Carmen Martínez, Mario Delgado, David Pozo et al. · Journal of Leukocyte Biology · 1998 · 155 citations

Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-alpha production by macrophages: in vitro and in vivo studies.

Mario Delgado, David Pozo, Carmen Martínez et al. · PubMed · 1999 · 153 citations

Vip Release, Immunology, Immune Regulation +21